{"organizations": [], "uuid": "d91ca3ff67a729d88e5363b52196f14694ce385b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180220.html", "section_title": "Archive News &amp; Video for Tuesday, 20 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-obalon-therapeutics-says-audit-com/brief-obalon-therapeutics-says-audit-committees-investigation-into-purported-whistleblower-complaint-concluded-allegations-are-meritless-idUSFWN1QA0FZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Obalon Therapeutics Says Audit Committee's Investigation Into Purported Whistleblower Complaint Concluded Allegations Are Meritless", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.024, "site_type": "news", "published": "2018-02-20T20:28:00.000+02:00", "replies_count": 0, "uuid": "d91ca3ff67a729d88e5363b52196f14694ce385b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-obalon-therapeutics-says-audit-com/brief-obalon-therapeutics-says-audit-committees-investigation-into-purported-whistleblower-complaint-concluded-allegations-are-meritless-idUSFWN1QA0FZ", "ord_in_thread": 0, "title": "BRIEF-Obalon Therapeutics Says Audit Committee's Investigation Into Purported Whistleblower Complaint Concluded Allegations Are Meritless", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "neutral"}, {"name": "obalon therapeutics inc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - Obalon Therapeutics Inc:\n* OBALON THERAPEUTICS - AUDIT COMMITTEE COMPLETED INVESTIGATION INTO PURPORTED WHISTLEBLOWER COMPLAINT; CONCLUDED ALLEGATIONS ARE MERITLESS\n* OBALON THERAPEUTICS - COMPLAINT RELATED TO SALES PROMOTION DURING Q4 AND ALLEGED THAT REVENUE RELATED TO THE PROMOTION WAS RECOGNIZED IMPROPERLY Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-20T20:28:00.000+02:00", "crawled": "2018-02-21T21:32:58.004+02:00", "highlightTitle": ""}